Author:
Inoue Osamu,Shukuri Miho,Hosoi Rie,Amitani Misato,Matsuura Nariaki,Hatazawa Jun,Takai Nobuhiko
Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging,General Medicine
Reference27 articles.
1. Wahl RL, Cody RL, Hutchins GD, Mudgett EE. Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose.Radiology 1991; 179:765–770.
2. Delbeke D. Oncological applications of FDG PET imaging: brain tumors, colorectal cancer, lymphoma and melanoma.J Nucl Med 1999; 40:591–603.
3. Ak I, Stokkel MP, Pauwels EK. Positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose in oncology. Part II. The clinical value in detecting and staging primary tumors.J Cancer Res Clin Oncol 2000; 126:560–574.
4. Okada J, Yoshikawa K, Itami M, Imaseki K, Uno K, Itami J, et al. Positron emission tomography using fluorine-18-fluorodeoxyglucose in malignant lymphoma: a comparison with proliferative activity.J Nucl Med 1992; 33:325–329.
5. Smith TAD, Titley J. Deoxyglucose uptake by head and neck squamous carcinoma: Influence of change in proliferative fraction.Int J Radiat Oncol Biol Phys 2000; 47:219–223.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献